Grensyn pharmaceutique private limited is registered as a pharmaceutical company on February 2016 and initially will be providing solutions for pharmaceutical dosage form development.
Pre-formulation & Analytical Development
Our perspective is that the comprehensive evaluation of drug candidates during pre-formulation is critical to the formulation development process. Therefore, every formulation project starts with a strategic formulation plan. Your drug candidate’s formulation strategy is developed from a thorough analysis of the preformulation data, the intended dosage form options, the expected manufacturing process, known issues, and the strategic goals of your company.
Product Formulation & Technology Transfer
At Grensyn, we know each formulation is unique, just as each drug candidate is unique. Certain candidates present specific challenges such as low bioavailability, poor solubility and/or permeability and instability. Anticipating potential issues prior to initiating formulation development activities can be helpful in overcoming many of these challenges. Our experience allows us to address issues before they become problems.
Grensyn supports contract drug development for the following:
- Solid Oral (Immediate release/extended release/delayed release, dispersible, chewable,orally disintegrating,bilayered tablets, capsules, powder for suspensions,immediate release/extended release/delayed release multiple unit pellets)
- Semi-solids (creams, ointments,gels)
- Liquids Oral (syrups,suspensions)
- Parenterals (Dry powder for Injections, Liquid Injections)
At Grensyn, our goal is to act as an extension of your team and in partnership, effectively develop your candidate for clinical trials, and ultimately, commercial distribution. In product development, it all comes down to the right people, their development experience and commitment. We are just the partner that can consistently deliver, project after project, building trust with our customers. Trust is the foundation of any successful relationship.